CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses
Cost of product revenue	$ 2,037	$ 2,019
Research and development	18,596	17,647
Sales and marketing	6,460	8,837
General and administrative	16,588	17,868
Impairment loss on intangible asset	371
Total operating expenses	44,052	46,371
Loss from operations	(34,291)	(34,415)
Interest expense	(6,382)	(12,723)
Change in fair value of freestanding and hybrid financial instruments designated at Fair Value Option	(5,125)	(20)
Gain (loss) on extinguishment of debt	3,697	(2,187)
Other income	200	950
Loss before income tax	(41,901)	(48,395)
Income tax expense
Net loss	(41,901)	(48,395)
Net loss attributable to noncontrolling interest	(601)	(941)
Net loss attributable to common stockholders	$ (41,300)	$ (47,454)
Net loss per share, basic	$ (1.79)	$ (36.18)
Net loss per share, diluted	$ (1.79)	$ (36.18)
Weighted-average common stock outstanding, basic	23,068,423	1,311,519
Weighted-average common stock outstanding, diluted	23,068,423	1,311,519
Product revenue, net
Revenue
Revenue	$ 9,761	$ 11,956